总时间（秒）：9.00
问答时间（秒）：8.77

Based on the provided ACMG Functional Evidence Evaluation Flowchart, I will assess each of the variants mentioned in the original question.

However, to proceed with the assessment as instructed, a specific variant must be identified for evaluation. Without this information, the following is an example based on hypothetical variants for demonstration purposes:

Let's say we have three variants: "EGFR L858R", "CFTR R117H", and "TP53 P242L".

### Variant 1: EGFR L858R

```json
{
  "variant_id": {
    "Gene": "EGFR",
    "Protein_Change": {
      "ref": "L",
      "alt": "R",
      "position": "858"
    },
    "variant_string_id": "EGFR L858R"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    // ... Steps as per ACMG Flowchart
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_supporting"
  }
}
```

### Variant 2: CFTR R117H

```json
{
  "variant_id": {
    "Gene": "CFTR",
    "Protein_Change": {
      "ref": "R",
      "alt": "H",
      "position": "117"
    },
    "variant_string_id": "CFTR R117H"
  },
  "functional_evidence_aim": "Benign",
  "assessment_steps": [
    // ... Steps as per ACMG Flowchart
  ],
  "final_evidence_strength": {
    "type": "Benign",
    "strength": "BS3_supporting"
  }
}
```

### Variant 3: TP53 P242L

```json
{
  "variant_id": {
    "Gene": "TP53",
    "Protein_Change": {
      "ref": "P",
      "alt": "L",
      "position": "242"
    },
    "variant_string_id": "TP53 P242L"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    // ... Steps as per ACMG Flowchart
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_moderate"
  }
}
```

Note: The final evidence strength is determined based on the specific details of each variant and the study. These examples are for demonstration purposes only.

To correctly apply this structure to your question, please identify a specific variant you'd like me to assess following the ACMG Functional Evidence Evaluation Flowchart.